Clinical trial
Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind…
NCT00001146 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00001146 |
|---|---|
| Title | Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial |
| Official title | Omega-3 Fatty Acids in the Treatment of Major Depression and Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Involutional Depression, Mood Disorder |
| Intervention type | Drug |
| Interventions | Ethyl Eicosapentaenoic Acid, OmegaBrite |
| Enrollment | 240 |
| Start date | Oct 1, 1999 |
| Completion | Aug 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: